-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下：CAKE公布的第一季度调整后每股收益为1.05美元，同比增长13%，高于市场普遍预期的1.01美元；总营收为9.79亿美元，同比增长5.6%，也高于市场普遍预期的9.65亿美元。调整后营业收入为5700万美元（同比增长7%），高于此前预期的5500万美元。尽管食品和劳动力成本均上涨了5%，但营业利润率仍保持在5.8%的稳定水平。这是利润率连续第三个季度保持稳定，表明管理层通过员工保留和供应链举措持续抵消成本波动，从而有效提升了运营效率。尽管受到天气因素的影响，但业绩仍超出预期。管理层重申了2026年开设至多26家新餐厅的计划，其中包括至多6家Cheesecake Factory门店以及多家North Italia、Flower Child和FRC品牌门店。该公司保持了 6.016 亿美元的强劲流动性，没有未偿债务，并通过 1920 万美元的股票回购和每季度 0.30 美元的股息返还了资本，这反映出对现金流的信心。
Related Articles
Asia
Electro Optic Systems Reports Contract Backlog Growth as of March 31
Electro Optic Systems Holdings (ASX:EOS) reported a contract backlog of AU$518 million as of March 31, up 13% from the end of 2025, according to a Thursday filing with the Australian bourse.The company closed the March quarter with unrestricted cash holdings of AU$95.1 million, representing a decrease of AU$11.8 million from the end of 2025, per the filing.
$ASX:EOS
Asia
Regis Healthcare Expects Fiscal 2026 Underlying EBITDA at Top End of Guidance
Regis Healthcare (ASX:REG) said it expects fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) of about AU$135 million, at the top end of guidance, according to a Thursday Australian bourse filing.Occupancy across mature homes averaged about 96% in the fiscal third quarter, per the filing.The company said it generated net refundable accommodation deposit (RAD) cash inflows of AU$44.5 million in the third quarter, taking the total net RAD cash inflows for the year to date to AU$223 million.As resident turnover occurs, the progressive repricing of existing paid-up RADs to current advertised room prices is expected to generate net operating cash inflows of about AU$400 million over time while also increasing RAD retention earnings, the company added.
$ASX:REG
Research
Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.
$MDLZ